TXA11114: Discovery of an <i>In Vivo</i> Efficacious Efflux Pump Inhibitor (EPI) That Potentiates Levofloxacin Against <i>Pseudomonas aeruginosa</i>

<b>Objectives:</b> Multidrug-resistant (MDR) <i>Pseudomonas aeruginosa</i> represents a major clinical challenge, driven in part by resistance–nodulation–division (RND) efflux pumps that reduce intracellular antibiotic concentrations and limit the efficacy of many antibacterial agents, including flu...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Jesus D. Rosado-Lugo, Pratik Datta, Ahmad Altiti, Yongzheng Zhang, Jun Lu, Yi Yuan, Ajit K. Parhi
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2026-03-01
Cyfres:	Antibiotics
Pynciau:	<i>P. aeruginosa</i> RND efflux pumps antimicrobial drug resistance efflux pump inhibitor indole carboxamide <i>in vivo</i> efficacy
Mynediad Ar-lein:	https://www.mdpi.com/2079-6382/15/4/346
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!